ICL Group Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $7.2B+4.6% YoYTTM through 31 Dec 2025
Net Income $280M-39.7% YoYTTM through 31 Dec 2025
Free Cash Flow $232MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 30.6% |
| EBITDA Margin | 18.3% |
| Operating Margin | 8.1% |
| Net Margin | 3.9% |
Returns
3.8%ROE
1.8%ROA
3.6%ROIC
Balance Sheet Health
Debt / Equity0.53x
Current Ratio1.33x
Net Debt$2.7B
Cash & Equivalents$291M
Quality Metrics
Piotroski F-Score3 / 9
FCF Margin3.2%
Rule of 4018.2
Earnings-Beat Rate66.7%
Multi-Year Trend
RevenueFY2025: $7.2B
Diluted EPSFY2025: $0.18
Dividend
$0.10Per share, FY20263.35%Yield1 yrsStreak-14.1%5-yr growth
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Phosphate Solutions | $2.3B | +5.3% | View detailsFocusing on specialty food solutions and specialty crop nutrition to drive profitable growth. |
| Potash | $1.7B | +3.5% | View detailsBenefiting from Dead Sea concession clarity and stable global demand. |
| Growing Solutions | $2.1B | +5.8% | View detailsPositioned to capture growth in specialty agriculture markets. |
| Industrial Products | $1.3B | +1.2% | View detailsPricing power in bromine expected to support margin expansion in 2026. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.